Specific properties of probiotic strains: relevance and benefits for the host

被引:84
作者
Bubnov, Rostyslav V. [1 ,2 ]
Babenko, Lidiia P. [1 ]
Lazarenko, Liudmyla M. [1 ]
Mokrozub, Victoria V. [1 ]
Spivak, Mykola Ya. [1 ,3 ]
机构
[1] Natl Acad Sci Ukraine, Zabolotny Inst Microbiol & Virol, Zabolotny Str 154, UA-03143 Kiev, Ukraine
[2] Clin Hosp Pheophania, State Affairs Dept, Zabolotny Str 21, UA-03143 Kiev, Ukraine
[3] PJSC SPC Diaproph Med, Svitlycky Str 35, UA-04123 Kiev, Ukraine
关键词
Predictive preventive personalized medicine; Lactobacillus; Bifidobacterium; Probiotics; Gut microbiota; Antibiotics; Gastric juice; Bile; Pancreatic enzymes; Adhesive properties; Pili; Patient phenotype; Individualized medicine; LACTOBACILLUS-RHAMNOSUS GG; LACTIC-ACID BACTERIA; GUT MICROBIOTA; ANTIBIOTIC-RESISTANCE; BIFIDOBACTERIUM; ADHESION; MODEL; PILI; DIET; INFLAMMATION;
D O I
10.1007/s13167-018-0132-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Probiotics have tremendous potential to develop healthy diets, treatment, and prevention. Investigation of in vitro cultural properties of health-promoting microorganisms like lactic acid bacteria (LAB) and bifidobacteria is crucial to select probiotic strains for treatments based on gut microbiota modulation to justify individualized and personalized approach for nutrition and prevention of variety of diseases. The aim was to study the biological properties of LAB and bifidobacteria probiotic strains, namely adhesive properties; resistance to antibiotics; and biological fluids (gastric juice, bile, pancreatic enzymes), and to overview the literature in the field. Material and methods We studied six LAB strains (Lactobacillus acidophilus IMV B-7279, L. casei IMV B-7280, L. delbrueckii subsp. bulgaricus IMV B-7281, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, L. plantarum LM VK7), and two bifidobacteria strains (Bifidobacterium animalis VKL, B. animalis VKB). We characterized tinctorial, culturally morphological, physiological, and biochemical properties of probiotic strains of LAB and bifidobacteria by commonly used research methods. Determination of the resistance to antibiotics was carried out using disc-diffusion method. The effects of gastric juice, bile, and pancreatin on the viability of LAB and bifidobacteria were evaluated. Adhesive properties of LAB and bifidobacteria to epithelial cells were assessed calculating three indicators: average adhesion rate (AAR), participation rate of epithelial cells (PRE), and adhesiveness index of microorganisms (AIM). Electron microscopy of LAB and bifidobacteria cells was conducted. Results The studied strains of LAB and bifidobacteria did not form spores, were positively stained by Gram, grow on medium in a wide range of pH (1.0-9.0, optimum pH 5.5-6.5), were sensitive to a wide range of antibiotics; and showed different resistance to gastric juice, bile, and pancreatic enzymes. The most resistant to antibiotics were L. rhamnosus LB-3 VK6 and L. delbrueckii LE VK8 strains. The most susceptible to gastric juice was L. plantarum LM VK7, which stopped its growth at 8% of gastric juice; L. acidophilus IMV B-7279, B. animalis VKL, and B. animalis VKB strains were resistant even in the 100% concentration. Strains L. acidophilus IMV B-7279, L. casei IMV B-7280, B. animalis VKL, B. animalis VKB, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, and L. delbrueckii subsp. bulgaricus IMV B-7281 were resistant to pancreatic enzymes. Adhesive properties of the strains according to AIM index were high in L. casei IMV D'-7280, B. animalis VKL, and B. animalis VKB; were moderate in L. delbrueckii subsp. bulgaricus IMV B-7281; and were low in L. acidophilus IMV B-7279, L. rhamnosus LB-3 VK6, L. delbrueckii LE VK8, and L. plantarum LM VK7. Conclusion We recognized strain-dependent properties of studied LAB and bifidobacteria probiotic strains (adhesive ability, resistance to antibiotics, and gut biological fluids) and discussed potential for most effective individualized treatment for gut and distant sites microbiome modulation.
引用
收藏
页码:205 / 223
页数:19
相关论文
共 109 条
[1]   Antiviral Potential of Lactic Acid Bacteria and Their Bacteriocins [J].
Al Kassaa, I. ;
Hober, D. ;
Hamze, M. ;
Chihib, N. E. ;
Drider, D. .
PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2014, 6 (3-4) :177-185
[2]   The gut microbiome, diet, and links to cardiometabolic and chronic disorders [J].
Aron-Wisnewsky, Judith ;
Clement, Karine .
NATURE REVIEWS NEPHROLOGY, 2016, 12 (03) :169-181
[3]  
Avdeeva L V, 2012, Mikrobiol Z, V74, P22
[4]  
Babenko L, 2017, 3 CEE M VIR HEP CO H, V9, P35
[5]  
Babenko L P, 2012, Mikrobiol Z, V74, P80
[6]   Heritable components of the human fecal microbiome are associated with visceral fat [J].
Beaumont, Michelle ;
Goodrich, Julia K. ;
Jackson, Matthew A. ;
Yet, Idil ;
Davenport, Emily R. ;
Vieira-Silva, Sara ;
Debelius, Justine ;
Pallister, Tess ;
Mangino, Massimo ;
Raes, Jeroen ;
Knight, Rob ;
Clark, Andrew G. ;
Ley, Ruth E. ;
Spector, Tim D. ;
Bell, Jordana T. .
GENOME BIOLOGY, 2016, 17
[7]   Probiotic Mechanisms of Action [J].
Bermudez-Brito, Miriam ;
Plaza-Diaz, Julio ;
Munoz-Quezada, Sergio ;
Gomez-Llorente, Carolina ;
Gil, Angel .
ANNALS OF NUTRITION AND METABOLISM, 2012, 61 (02) :160-174
[8]   ADHESION OF HUMAN BIFIDOBACTERIAL STRAINS TO CULTURED HUMAN INTESTINAL EPITHELIAL-CELLS AND INHIBITION OF ENTEROPATHOGEN-CELL INTERACTIONS [J].
BERNET, MF ;
BRASSART, D ;
NEESER, JR ;
SERVIN, AL .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1993, 59 (12) :4121-4128
[9]   Technical guidance Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance Prepared by the Panel on Additives and Products or Substances used in Animal Feed [J].
Bories, Georges ;
Brantom, Paul ;
de Barbera, Joaquim Brufau ;
Chesson, Andrew ;
Cocconcelli, Pier Sandro ;
Debski, Bogdan ;
Dierick, Noel ;
Franklin, Anders ;
Gropp, Juergen ;
Halle, Ingrid ;
Hogstrand, Christer ;
de Knecht, Joop ;
Leng, Lubomir ;
Haldorsen, Anne-Katrine Lundebye ;
Mantovani, Alberto ;
Mezes, Miklos ;
Nebbia, Carlo ;
Rambeck, Walter ;
Rychen, Guido ;
von Wright, Atte ;
Wester, Pieter .
EFSA JOURNAL, 2008, 6 (07)
[10]   General scientific guidance for stakeholders on health claim applications [J].
Bresson, Jean Louis ;
Burlingame, Barbara ;
Dean, Tara ;
Fairweather-Tait, Susan ;
Heinonen, Marina ;
Hirsch-Ernst, Karen Ildico ;
Mangelsdorf, Inge ;
McArdle, Harry ;
Naska, Androniki ;
Neuhauser-Berthold, Monika ;
Nowicka, Grazyna ;
Pentieva, Kristina ;
Sanz, Yolanda ;
Siani, Alfonso ;
Sjodin, Anders ;
Stern, Martin ;
Tome, Daniel ;
Turck, Dominique ;
Van Loveren, Hendrik ;
Vinceti, Marco ;
Willatts, Peter .
EFSA JOURNAL, 2016, 14 (01)